Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Harrow Health, Inc. (HROW)

10.87   0.18 (1.68%) 11-25 13:00
Open: 10.76 Pre. Close: 10.69
High: 10.87 Low: 10.61
Volume: 31,121 Market Cap: 298(M)

Technical analysis

as of: 2022-11-25 1:57:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 13.62     One year: 14.78
Support: Support1: 10.06    Support2: 8.36
Resistance: Resistance1: 11.66    Resistance2: 12.65
Pivot: 10.99
Moving Average: MA(5): 10.53     MA(20): 11.31
MA(100): 9.5     MA(250): 8.27
MACD: MACD(12,26): -0.3     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 24.6     %D(3): 17.6
RSI: RSI(14): 46.6
52-week: High: 13.28  Low: 5.4
Average Vol(K): 3-Month: 205 (K)  10-Days: 143 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ HROW ] has closed above bottom band by 43.8%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.75 - 10.8 10.8 - 10.84
Low: 10.28 - 10.33 10.33 - 10.38
Close: 10.61 - 10.69 10.69 - 10.76

Company Description

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Headline News

Fri, 18 Nov 2022
B. Riley Comments on Harrow Health, Inc.'s FY2022 Earnings (NASDAQ:HROW) - MarketBeat

Wed, 16 Nov 2022
Short Interest in Harrow Health, Inc. (NASDAQ:HROW) Expands By 13.8% - MarketBeat

Mon, 14 Nov 2022
Harrow Health Earnings, Revenue Miss in Q3 By -

Mon, 14 Nov 2022
Harrow: Q3 Earnings Snapshot - Chron

Mon, 14 Nov 2022
Harrow Health, Inc. (HROW) Q3 2022 Earnings Call Transcript - Seeking Alpha

Thu, 10 Nov 2022
2022-11-10 | NDAQ:HROW | Press Release | Harrow Health Inc. - Stockhouse

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 27 (M)
Shares Float 22 (M)
% Held by Insiders 8 (%)
% Held by Institutions 57.4 (%)
Shares Short 858 (K)
Shares Short P.Month 747 (K)

Stock Financials

EPS -0.78
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.05
Profit Margin (%) -25.5
Operating Margin (%) 4.1
Return on Assets (ttm) 2.2
Return on Equity (ttm) -264
Qtrly Rev. Growth 22
Gross Profit (p.s.) 2
Sales Per Share 3.26
EBITDA (p.s.) 0.23
Qtrly Earnings Growth 0
Operating Cash Flow 4 (M)
Levered Free Cash Flow 22 (M)

Stock Valuations

PE Ratio -13.94
PEG Ratio -1.5
Price to Book value 217.39
Price to Sales 3.32
Price to Cash Flow 74.87

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.